Murray Fleming - Glucose Health CEO, CFO, Director
| GLUC Stock | USD 0.45 0.05 10.00% |
CEO
Mr. Murray S. Fleming is Chief Executive Officer, Chief Financial Officer, Director of Company. He was Chief Executive Officer of the Company., effective October 1, 2014. From 2006 to the present date, Mr. Fleming was the principal of BTB Management LLC, an organization offering business planning and market research, investor relations services and publications. Additionally, since 2006, Mr. Fleming was the largest shareholder of Ryox Corporation, a privately held investment company since 2016.
| Age | 60 |
| Tenure | 8 years |
| Phone | 479 802 3827 |
| Web | https://www.glucosehealthinc.com |
Glucose Health Management Efficiency
The company has return on total asset (ROA) of (0.28) % which means that it has lost $0.28 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5016) %, meaning that it created substantial loss on money invested by shareholders. Glucose Health's management efficiency ratios could be used to measure how well Glucose Health manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 9 records | CEO Age | ||
| John Ranelli | Central Garden Pet | 71 | |
| Geoff Tanner | Simply Good Foods | 49 | |
| Darcy Davenport | Bellring Brands LLC | 51 | |
| Steven Fife | Lifevantage | 63 | |
| Darren Jensen | Lifevantage | 46 | |
| Joseph Scalzo | Simply Good Foods | 65 | |
| R Birla | Simply Good Foods | 59 | |
| John Ranelli | Central Garden Pet | 71 | |
| Kraig Kayser | Seneca Foods Corp | 57 | |
Management Performance
| Return On Equity | -0.5 | |||
| Return On Asset | -0.28 |
Glucose Health Leadership Team
Elected by the shareholders, the Glucose Health's board of directors comprises two types of representatives: Glucose Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Glucose. The board's role is to monitor Glucose Health's management team and ensure that shareholders' interests are well served. Glucose Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Glucose Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| William Gallagher, Advisor Board | ||
| Murray Fleming, CEO, CFO, Director | ||
| Peggy Knight, Chief Marketing Officer | ||
| Chandrasekhar Mallangi, Advisor Science |
Glucose Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Glucose Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.5 | |||
| Return On Asset | -0.28 | |||
| Profit Margin | (0.32) % | |||
| Operating Margin | (0.32) % | |||
| Current Valuation | 1.16 M | |||
| Shares Outstanding | 4.55 M | |||
| Shares Owned By Insiders | 10.14 % | |||
| Shares Owned By Institutions | 0.25 % | |||
| Price To Earning | (1.99) X | |||
| Price To Sales | 3.42 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Glucose Health in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Glucose Health's short interest history, or implied volatility extrapolated from Glucose Health options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Glucose Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Complementary Tools for Glucose Pink Sheet analysis
When running Glucose Health's price analysis, check to measure Glucose Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Glucose Health is operating at the current time. Most of Glucose Health's value examination focuses on studying past and present price action to predict the probability of Glucose Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Glucose Health's price. Additionally, you may evaluate how the addition of Glucose Health to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |